Search
for

    Sort by

    Community Join

    150-161 / 161 results

      community Verteporfin (Visudyne) group buy 🌷

      in Treatment  29 upvotes 2 years ago
      User seeks participants for Verteporfin group buy. Verteporfin, FDA approved, may regenerate hair follicles and sweat glands through heavy microneedling.

      community I’m just Going to let Nature take its Course

      in Chat  213 upvotes 1 year ago
      The post and conversation are about a 23-year-old deciding to stop using finasteride for hair loss due to potential erectile dysfunction risks, sparking a debate about the benefits and side effects of hair loss treatments.

      community Fin 1 year, not looking better

      in Treatment  7 upvotes 2 years ago
      The user has been taking finasteride for a year without improvement and added minoxidil and dermarolling recently, but hair loss continues. Blood tests showed normal testosterone and vitamins, except for low vitamin D3 and an allergy, which doctors suggested could be causing the hair loss.

      community One Month on Topical Fin and Min Experience

      in Update  10 upvotes 7 months ago
      A 27-year-old male started using topical finasteride (0.25%) and minoxidil (5%) once daily, along with supplements like zinc, magnesium, biotin, and vitamins C and D. After initial concerns about side effects, he experienced temporary ED and shedding but now feels better and has no regrets about starting the treatment.

      community Trying to understand finasteride side effects and post finasteride syndrome

      in Finasteride/Dutasteride  67 upvotes 3 years ago
      The conversation discusses the side effects of finasteride, including low libido and erectile dysfunction, and the possibility of these effects being permanent, known as post-finasteride syndrome (PFS). Some users report personal experiences with PFS and debate whether the condition is real, with varying opinions on the reversibility of side effects and the role of individual biology.

      community The story of RU58841/PSK3841

      in Research/Science 2 weeks ago
      RU58841, an anti-androgenic compound, showed early promise for treating alopecia but faced challenges after its patent in 1997. Despite advancing to Phase II trials, safety concerns and financial struggles led Aventis to abandon its development. Proskelia, which later merged into ProStrakan, couldn't prioritize the drug, leading to its eventual stagnation and failure to reach the market.

      community Selling a premixed KY19382 solution

      in Research/Science  6 upvotes 2 years ago
      The conversation discusses the sale of a premixed KY19382 solution for research purposes, highlighting previous unsuccessful group buys and the formulation process. Prices and purchasing options for KY19382 solutions and powder are provided.